60 Degrees Pharmaceuticals (SXTP) Return on Invested Capital (2023 - 2025)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Return on Invested Capital of 7.13% for Q3 2025, down 287.0% year-over-year from 3.81% in Q3 2024, and down 3.23% quarter-over-quarter from 6.9% in Q2 2025.
60 Degrees Pharmaceuticals (SXTP) Return on Invested Capital (2023 - 2025) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Return on Invested Capital for 3 consecutive years, with 7.13% the latest figure, recorded in Q3 2025.
- In Q3 2025, Return on Invested Capital fell 287.0% year-over-year to 7.13%; the TTM figure through Sep 2025 stood at 7.13% (down 287.0% YoY), while the FY2024 annual figure was 6.85%, down 682.0% from the prior year.
- Return on Invested Capital declined to 7.13% in Q3 2025 per SXTP's latest filing, from 6.9% in the prior quarter.
- Across five years, Return on Invested Capital topped out at 0.0% in Q3 2023 and bottomed at 7.13% in Q3 2025.
- Historically, Return on Invested Capital has averaged 2.87% across 3 years, with a median of 1.92% in 2024.
- Annual changes were most pronounced in 2024 — Return on Invested Capital decreased 1 bps — and 2025, when it tumbled 690 bps.
- 60 Degrees Pharmaceuticals' Return on Invested Capital stood at 0.0% in 2023, then sank by 191273 bps to 3.84% in 2024, then plunged by 86 bps to 7.13% in 2025.
- Business Quant data shows SXTP's Return on Invested Capital at 7.13% in Q3 2025, 6.9% in Q2 2025, and 6.54% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -7.13% |
| Jun 30, 2025 | -6.90% |
| Mar 31, 2025 | -6.54% |
| Dec 31, 2024 | -3.84% |
| Sep 30, 2024 | -4.26% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |